SlideShare a Scribd company logo
1 of 52
128 June 2014
Adrenergic Agonists
Pharmacology I/ Lecture 6
Dr. Hiwa K. Saaed, HD, MSc. PhD
28 June 2014 2
I. Direct-Acting
• A. Epinephrine (α1, α2, β1, β2)
1.At low doses, β effects (vasodilation) on the
vascular system predominate,
2.whereas at high doses, α effects
(vasoconstriction) are strongest.
28 June 2014 3
Cardiovascular Actions:
Cardiovascular:
• β1 action: positive inotropic & chronotropic.
• α effects : constricts arterioles in the skin, mucous
membranes, and viscera.
• β2 effects: dilates vessels going to the liver and skeletal
muscle.
• Renal blood flow is decreased.
• Therefore, the cumulative effect is an increase in systolic
blood pressure, coupled with a slight decrease in
diastolic pressure
28 June 2014 4
28 June 2014 5
Respiratory Actions
Respiratory:
• β2 action: powerful bronchodilation. Epinephrine also
inhibits the release of allergy mediators such as
histamines from mast cells.
This action relieves all known allergic- or histamine-
induced bronchoconstriction.
In the case of anaphylactic shock, this can be lifesaving.
In individuals suffering from an acute asthmatic attack,
epinephrine
1. rapidly relieves the dyspnea (labored breathing)
2. increases the tidal volume (volume of gases inspired
and expired).
28 June 2014 6
Metabolic Actions
• Significant hyperglycemia: because of
β2 effect: increased glycogenolysis in the liver,
β2 effect: increased release of glucagon
α2 effect: a decreased release of insulin.
28 June 2014 7
Actions
• Lipolysis: through its agonist activity on the β
receptors of adipose tissue,
• which upon stimulation activate adenylyl cyclase
to increase cAMP levels.
• Cyclic AMP stimulates a hormone-sensitive
lipase,
• which hydrolyzes triacylglycerols to free fatty
acids and glycerol.
28 June 2014 8
Therapeutic uses
• Bronchospasm: in treatment of acute asthma
and anaphylactic shock, epinephrine is the drug of
choice; within a few minutes after SC
administration, greatly improved respiratory
exchange is observed.
• Anaphylactic shock: Epinephrine is the drug of
choice for the treatment of Type I hypersensitivity
reactions in response to allergens.
28 June 2014 9
Therapeutic uses
• Glaucoma: In ophthalmology, a 2%
epinephrine solution may be used topically to
reduce IOP in open-angle glaucoma.
• It reduces the production of aqueous humor by
vasoconstriction of the ciliary body blood
vessels.
• Cardiac arrest: Epinephrine may be used to
restore cardiac rhythm in patients with cardiac
arrest regardless of the cause.
Therapeutic uses
• Anesthetics: Local anesthetic solutions usually
contain 1:100,000 parts epinephrine. The effect
of the drug is to greatly increase the duration of
the local anesthesia.
• Very weak solutions of epinephrine (1:100,000)
can also be used topically to vasoconstrict
mucous membranes to control oozing of capillary
blood.
28 June 2014 10
28 June 2014 11
Pharmacokinetics:
• Epinephrine has a rapid onset but a brief duration of action
• In emergency situations, epinephrine is given I.V. It may
also be given SC, by endotracheal tube, by inhalation, or
topically to the eye.
• Oral administration is ineffective, because ?
• Only metabolites are excreted in the urine.
28 June 2014 12
Adverse effects:
• CNS disturbances: include anxiety, fear, tension,
headache, and tremor.
• Cerebral Hemorrhage: as a result of a marked
elevation of blood pressure.
• Cardiac arrhythmias: particularly if the patient is
receiving digitalis.
• Pulmonary edema.
28 June 2014 13
B. Norepinephrine (α1, α2, β1)
• It should theoretically stimulate all types
of adrenergic receptors.
• In therapeutic doses, the α-adrenergic
receptor is most affected.
28 June 2014 14
Cardiovascular actions:
• Vasoconstriction: increase in peripheral resistance due
to intense vasoconstriction of most vascular beds,
including the kidney (α1 effect).
• Both systolic and diastolic blood pressures increase.
• Note: Norepinephrine causes greater vasoconstriction
than does epinephrine,
• because it does not induce compensatory vasodilation via
β2 receptors on blood vessels supplying skeletal muscles,
etc.
• The weak β2 activity of norepinephrine also explains why
it is not useful in the treatment of asthma.
28 June 2014 15
28 June 2014 16
• Baroreceptor reflex: In isolated cardiac tissue,
norepinephrine stimulates cardiac contractility;
however, in vivo, no cardiac stimulation is noted.
• This is due to the increased blood pressure that
induces a reflex rise in vagal activity by
stimulating the baroreceptors.
• This reflex bradycardia is sufficient to counteract
the local actions of norepinephrine on the heart,.
Cardiovascular actions:
28 June 2014 17
Effect of atropine pretreatment:
• If atropine, which blocks the transmission
of vagal effects, is given before
norepinephrine, then norepinephrine
stimulation of the heart is evident as
tachycardia.
28 June 2014 18
Therapeutic uses:
• Shock
However, metaraminol is favored, because it
does not reduce blood flow to the kidney,
as does norepinephrine.
28 June 2014 19
• Other actions of norepinephrine are not
considered to be clinically significant.
• It is never used for asthma or in combination
with local anesthetics.
• Norepinephrine is a potent vasoconstrictor and
will cause extravasation (discharge of blood from
vessel into tissues) along the injection site.
Therapeutic uses:
28 June 2014 20
C. Isoproterenol (β1- and β2)
• is a direct-acting synthetic catecholamine
• predominantly stimulates both β1- and β2.
• Its nonselectivity is one of its drawbacks
and the reason why it is rarely used
therapeutically.
• Its action on α receptors is insignificant.
28 June 2014 21
Actions:
• Cardiovascular:
• β1 effect: increase heart rate and force of contraction,
causing increased CO. It is useful in the treatment of
atrioventricular block or cardiac arrest.
• β2 effect: dilates the arterioles of skeletal muscle ,
resulting in decreased peripheral resistance.
• Because of its cardiac stimulatory action, it may increase
systolic blood pressure slightly, but it greatly reduces
mean arterial and diastolic blood pressure.
• Other effects on β receptors, such as increased blood
sugar and lipolysis.
28 June 2014 22
28 June 2014 23
Therapeutic uses:
Isoproterenol
• is now rarely used as a bronchodilator in asthma.
• It can be employed to stimulate the heart in
emergency situations
28 June 2014 24
28 June 2014 25
D. Dopamine (D1 and D2, β1, α1)
• Dopamine can activate α- and β-adrenergic receptors,
• at higher doses, it can cause vasoconstriction by
activating α1 receptors,
• whereas at lower doses, it stimulates β1 cardiac
receptors.
• In addition, D1 and D2 dopaminergic receptors, occur in
the peripheral mesenteric and renal vascular beds, where
binding of dopamine produces vasodilation.
28 June 2014 26
Actions:
• Cardiovascular: β1, α1 receptors
• Renal and visceral: Dopamine dilates renal and
splanchnic arterioles by activating dopaminergic
receptors, thus increasing blood flow to the
kidneys and other viscera.
• Therefore, dopamine is clinically useful in the
treatment of shock, in which significant
increases in sympathetic activity might
compromise renal function.
28 June 2014 27
Therapeutic uses:
• Shock: Dopamine is the drug of choice for shock and is
given by continuous infusion. It raises the blood pressure
by stimulating the:
• β1 receptors on the heart to increase cardiac output,
• α1 receptors on blood vessels to increase total peripheral
resistance.
• In addition, it enhances perfusion to the kidney and
splanchnic areas, An increased blood flow to the kidney
enhances the glomerular filtration rate and causes
sodium diuresis.
• In this regard, dopamine is far superior to
norepinephrine, which diminishes the blood supply to the
kidney and may cause renal shutdown.
28 June 2014 28
E. Dobutamine (β1)
• is a synthetic, direct-acting catecholamine
that is a β1-receptor agonist.
• It increases cardiac rate and output with
few vascular effects.
28 June 2014 29
Therapeutic uses:
• CHF: to increase CO in congestive heart
failure as well as for inotropic support
after cardiac surgery.
• The drug increases cardiac output with
little change in heart rate, and it does not
significantly elevate oxygen demands of
the myocardium a major advantage over
other sympathomimetic drugs.
28 June 2014 30
F. Oxymetazoline (α1 and α2)
• Oxymetazoline is a direct-acting synthetic
adrenergic agonist that stimulates both α1- and
α2-adrenergic receptors.
• It is primarily used locally in the eye or the nose
as a vasoconstrictor.
• Oxymetazoline is found in many over-the-
counter short-term nasal spray decongestant
products as well as in ophthalmic drops for the
relief of redness of the eyes associated with
swimming, colds, or contact lens.
28 June 2014 31
The mechanism of action
• The mechanism of action of oxymetazoline is direct
stimulation of α receptors on blood vessels supplying the
nasal mucosa and the conjunctiva to reduce blood flow
and decrease congestion.
• Oxymetazoline is absorbed in the systemic circulation
regardless of the route of administration and may
produce nervousness, headaches, and trouble sleeping.
When administered in the nose, burning of the nasal
mucosa and sneezing may occur.
• Rebound congestion is observed with long-term use.
28 June 2014 32
G. Phenylephrine (α1)
• Phenylephrine is a direct-acting, synthetic
adrenergic drug that binds primarily to α
receptors and favors α1 receptors over α2
receptors.
• Phenylephrine is a vasoconstrictor that raises
both systolic and diastolic blood pressures.
• It has no effect on the heart itself but rather
induces reflex bradycardia when given
parenterally.
28 June 2014 33
Phenylphrine
• It is often used topically on the nasal mucous
membranes as decongestant and in ophthalmic
solutions for mydriasis.
• The drug is used to raise blood pressure and to
terminate episodes of supraventricular
tachycardia.
• Large doses can cause hypertensive headache
and cardiac irregularities.
28 June 2014 34
H. Methoxamine (α1)
• Methoxamine is a direct-acting, synthetic
adrenergic drug that binds primarily to α
receptors, with α1 receptors favored over
α2 receptors.
• Methoxamine raises blood pressure by
stimulating α1 receptors in the arterioles,
causing vasoconstriction. This causes an
increase in total peripheral resistance.
28 June 2014 35
Methoxamine
• Clinically used to relieve attacks of paroxysmal
supraventricular tachycardia.
• It is also used to overcome hypotension during
surgery involving halothane anesthetics.
• In contrast to most other adrenergic drugs,
methoxamine does not tend to trigger cardiac
arrhythmias in the heart, which is sensitized by
these general anesthetics.
• Adverse effects include hypertensive headache
and vomiting.
28 June 2014 36
I. Clonidine (α2)
• Clonidine is an α2 agonist; acts centrally to
produce inhibition of sympathetic vasomotor
centers, decreasing sympathetic outflow to the
periphery.
• used in essential hypertension to lower blood
pressure.
• It can be used to minimize the symptoms that
accompany withdrawal from opiates or
benzodiazepines.
28 June 2014 37
J. Metaproterenol (β2)
• It can be administered orally or by inhalation.
• The drug acts primarily at β2 receptors,
producing little effect on the heart.
• The drug is useful as a bronchodilator in the
treatment of asthma and to reverse
bronchospasm.
28 June 2014 38
K. Albuterol, pirbuterol, and terbutaline (β2)
• are short-acting β2 agonists used primarily
as bronchodilators and administered by a
metered-dose inhaler.
• Compared with the nonselective β-
adrenergic agonists, such as
metaproterenol, these drugs produce
equivalent bronchodilation with less
cardiac stimulation.
28 June 2014 39
L. Salmeterol and formoterol (β2)
• are β2-adrenergic selective, long-acting bronchodilators.
over 12 hours, compared with less than 3 hours for
albuterol.
• Unlike formoterol, however, salmeterol has a somewhat
delayed onset of action.
• These agents are not recommended as monotherapy
and are highly efficacious when combined with a
corticorsteroid.
• Salmeterol and formoterol are the agents of choice for
treating nocturnal asthma in symptomatic patients taking
other asthma medications.
28 June 2014 40
28 June 2014 41
II. Indirect-Acting Adrenergic Agonists
• cause norepinephrine release from
presynaptic terminals or inhibit the uptake
of norepinephrine.
• Thus, they potentiate the effects of
norepinephrine produced endogenously,
• but these agents do not directly affect
postsynaptic receptors.
28 June 2014 42
A. Amphetamine
• The marked central stimulatory action of amphetamine is
often mistaken by drug abusers as its only action.
• However, the drug can increase blood pressure
significantly by α-agonist action on the vasculature as
well as β-stimulatory effects on the heart.
28 June 2014 43
Uses
The CNS stimulant effects of amphetamine
and its derivatives have led to their use for
treating:
1. hyperactivity in children,
2. narcolepsy,
3. and appetite control.
Its use in pregnancy should be avoided
28 June 2014 44
B. Tyramine
• Tyramine is not a clinically useful drug, but it is
important because it is found in fermented foods, such
as ripe cheese and Chianti wine. It is a normal
byproduct of tyrosine metabolism.
• Normally, it is oxidized by MAO in the gastrointestinal
tract, but if the patient is taking MAO inhibitors, it can
precipitate serious vasopressor episodes.
• Like amphetamines, tyramine can enter the nerve
terminal and displace stored norepinephrine. The
released catecholamine then acts on adrenoceptors.
28 June 2014 45
C. Cocaine
• Cocaine is unique among local anesthetics in having the
ability to block the Na+/K+-activated ATPase (required
for cellular uptake of norepinephrine) on the cell
membrane of the adrenergic neuron.
• Consequently, norepinephrine accumulates in the
synaptic space,
• Like amphetamines, it can increase blood pressure by α-
agonist actions and β-stimulatory effects.
• Cocaine as a CNS stimulant and drug of abuse.
28 June 2014 46
VI. Mixed-Action Adrenergic
Agonists
1. induce the release of norepinephrine
from presynaptic terminals,
2. and they activate adrenergic receptors on
the postsynaptic membrane.
28 June 2014 47
A. Ephedrine and pseudoephedrine
• Are plant alkaloids that are now made
synthetically.
• are not catechols and are poor substrates
for COMT and MAO; thus, these drugs
have a long duration of action.
• have excellent absorption orally and
penetrate into the CNS; however,
pseudoephedrine has fewer CNS effects.
28 June 2014 48
A. Ephedrine and pseudoephedrine
• Ephedrine raises systolic and diastolic blood
pressures by vasoconstriction and cardiac
stimulation.
• Ephedrine produces bronchodilation, but it is less
potent than epinephrine or isoproterenol in this
regard and produces its action more slowly.
• It is therefore sometimes used prophylactically
in chronic treatment of asthma to prevent attacks
rather than to treat the acute attack.
28 June 2014 49
A. Ephedrine and pseudoephedrine
• Ephedrine enhances contractility and improves
motor function in myasthenia gravis, particularly
when used in conjunction with
anticholinesterases.
• Ephedrine produces a mild stimulation of the
CNS. This increases alertness, decreases fatigue,
and prevents sleep. It also improves athletic
performance.
28 June 2014 50
A. Ephedrine and pseudoephedrine
• Ephedrine has been used to treat asthma, as a
nasal decongestant (due to its local
vasoconstrictor action), and to raise blood
pressure.
• Note: The clinical use of ephedrine is declining
due to the availability of better, more potent
agents that cause fewer adverse effects.
• Pseudoephedrine is primarily used to treat nasal
and sinus congestion or congestion of the
eustachian tubes.
28 June 2014 51
A. Ephedrine and pseudoephedrine
• Ephedrine-containing herbal supplements
(mainly ephedra-containing products) were
banned by the Food and Drug Administration
(FDA) in April 2004 because of life-threatening
cardiovascular reactions.
• Pseudoephedrine has been illegally converted to
methamphetamine. Thus, products containing
pseudoephedrine have certain restrictions and
must be kept behind the sales counter.]
28 June 2014 52
B. Metaraminol:
• mixed acting sympathomimetic similar to NE in
its action although it is less potent.
• Increase systolic and diastolic BP via
vasoconstriction and rapid marked reflex
bradycardia.
• Rx of hypotension and termination of PAT
episodes.

More Related Content

What's hot

Fibrinolytics & antiplatelets
Fibrinolytics & antiplateletsFibrinolytics & antiplatelets
Fibrinolytics & antiplateletsNaser Tadvi
 
Barbiturates and benzodiazepines acute poisoning
Barbiturates and benzodiazepines acute poisoningBarbiturates and benzodiazepines acute poisoning
Barbiturates and benzodiazepines acute poisoningvelspharmd
 
Neuromuscular blocker
Neuromuscular blockerNeuromuscular blocker
Neuromuscular blockerOmkumar Patel
 
Muscle relaxant laith
Muscle relaxant laithMuscle relaxant laith
Muscle relaxant laithLaith Alasadi
 
NAC, Physostigmine & Neostigmine: Their efficacy as antidote - By RxVichu!!! ...
NAC, Physostigmine & Neostigmine: Their efficacy as antidote - By RxVichu!!! ...NAC, Physostigmine & Neostigmine: Their efficacy as antidote - By RxVichu!!! ...
NAC, Physostigmine & Neostigmine: Their efficacy as antidote - By RxVichu!!! ...RxVichuZ
 
03. antiplatelets. fibrinolytics ims pptx
03. antiplatelets. fibrinolytics ims pptx03. antiplatelets. fibrinolytics ims pptx
03. antiplatelets. fibrinolytics ims pptxDr Pralhad Patki
 
Antihypertensive mbbs copy
Antihypertensive mbbs   copyAntihypertensive mbbs   copy
Antihypertensive mbbs copyDivya Krishnan
 
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersSkeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersPranav Bansal
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agentsKirti Vadi
 
Adrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blockerAdrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blockerSubramani Parasuraman
 
Oral hypoglycemics
Oral hypoglycemicsOral hypoglycemics
Oral hypoglycemicsankit
 
UNIT II SYMPATHOLYTIC AGENTS
UNIT II SYMPATHOLYTIC AGENTSUNIT II SYMPATHOLYTIC AGENTS
UNIT II SYMPATHOLYTIC AGENTSSONALI PAWAR
 
2nd year anti-anginal_drugs
2nd year anti-anginal_drugs2nd year anti-anginal_drugs
2nd year anti-anginal_drugsUttara Joshi
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectorisrx_sonali
 
Adrenergic antagonists alpha and beta blockers
Adrenergic antagonists   alpha and beta blockersAdrenergic antagonists   alpha and beta blockers
Adrenergic antagonists alpha and beta blockersZulcaif Ahmad
 
Pharmacology antiarrhythmias
Pharmacology   antiarrhythmiasPharmacology   antiarrhythmias
Pharmacology antiarrhythmiasMBBS IMS MSU
 

What's hot (20)

Epilepsy - pharmacology
Epilepsy - pharmacologyEpilepsy - pharmacology
Epilepsy - pharmacology
 
Fibrinolytics & antiplatelets
Fibrinolytics & antiplateletsFibrinolytics & antiplatelets
Fibrinolytics & antiplatelets
 
Barbiturates and benzodiazepines acute poisoning
Barbiturates and benzodiazepines acute poisoningBarbiturates and benzodiazepines acute poisoning
Barbiturates and benzodiazepines acute poisoning
 
Neuromuscular blocker
Neuromuscular blockerNeuromuscular blocker
Neuromuscular blocker
 
Muscle relaxant laith
Muscle relaxant laithMuscle relaxant laith
Muscle relaxant laith
 
NAC, Physostigmine & Neostigmine: Their efficacy as antidote - By RxVichu!!! ...
NAC, Physostigmine & Neostigmine: Their efficacy as antidote - By RxVichu!!! ...NAC, Physostigmine & Neostigmine: Their efficacy as antidote - By RxVichu!!! ...
NAC, Physostigmine & Neostigmine: Their efficacy as antidote - By RxVichu!!! ...
 
03. antiplatelets. fibrinolytics ims pptx
03. antiplatelets. fibrinolytics ims pptx03. antiplatelets. fibrinolytics ims pptx
03. antiplatelets. fibrinolytics ims pptx
 
Sympathomimetics
SympathomimeticsSympathomimetics
Sympathomimetics
 
Antihypertensive mbbs copy
Antihypertensive mbbs   copyAntihypertensive mbbs   copy
Antihypertensive mbbs copy
 
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersSkeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
 
Adrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blockerAdrenergic drugs β adrenergic blocker
Adrenergic drugs β adrenergic blocker
 
Oral hypoglycemics
Oral hypoglycemicsOral hypoglycemics
Oral hypoglycemics
 
UNIT II SYMPATHOLYTIC AGENTS
UNIT II SYMPATHOLYTIC AGENTSUNIT II SYMPATHOLYTIC AGENTS
UNIT II SYMPATHOLYTIC AGENTS
 
2nd year anti-anginal_drugs
2nd year anti-anginal_drugs2nd year anti-anginal_drugs
2nd year anti-anginal_drugs
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Adrenergic antagonists alpha and beta blockers
Adrenergic antagonists   alpha and beta blockersAdrenergic antagonists   alpha and beta blockers
Adrenergic antagonists alpha and beta blockers
 
Hypertension
HypertensionHypertension
Hypertension
 
Pharmacology antiarrhythmias
Pharmacology   antiarrhythmiasPharmacology   antiarrhythmias
Pharmacology antiarrhythmias
 
Pharmacology of Drugs Used to Treat Asthma
Pharmacology of Drugs Used to Treat AsthmaPharmacology of Drugs Used to Treat Asthma
Pharmacology of Drugs Used to Treat Asthma
 

Viewers also liked

Autonomic nervous system lecture 5
Autonomic nervous system lecture 5 Autonomic nervous system lecture 5
Autonomic nervous system lecture 5 Hassan Almalah
 
Antidepressants /certified fixed orthodontic courses by Indian dental academy
Antidepressants  /certified fixed orthodontic courses by Indian dental academy Antidepressants  /certified fixed orthodontic courses by Indian dental academy
Antidepressants /certified fixed orthodontic courses by Indian dental academy Indian dental academy
 
Pharmacology of adrenergic neuron blockers
Pharmacology of adrenergic neuron blockersPharmacology of adrenergic neuron blockers
Pharmacology of adrenergic neuron blockersShahan Ullah
 
Adrenergic agents lady ann
Adrenergic agents   lady annAdrenergic agents   lady ann
Adrenergic agents lady annLeeds Francisco
 
Anti depressent drugs
Anti depressent drugsAnti depressent drugs
Anti depressent drugsalaa salem
 
Reversal action of Acetylcholine on blood pressure in dog
Reversal action of Acetylcholine on blood pressure in dogReversal action of Acetylcholine on blood pressure in dog
Reversal action of Acetylcholine on blood pressure in dogSameh Abdel-ghany
 
adrenergic agonists & antagonists
adrenergic agonists & antagonistsadrenergic agonists & antagonists
adrenergic agonists & antagonistsdrjawaria73
 
Dr. baltazar s adrenergic agonists
Dr. baltazar s adrenergic agonistsDr. baltazar s adrenergic agonists
Dr. baltazar s adrenergic agonistsMaria Alonieh Sepe
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part IIBrian Piper
 
05 antidepressants by ravikiran
05 antidepressants by ravikiran 05 antidepressants by ravikiran
05 antidepressants by ravikiran Ravi Kiran
 
Anticholinergic pharmacology
Anticholinergic pharmacologyAnticholinergic pharmacology
Anticholinergic pharmacologyNunkoo Raj
 
ans lecture1
ans lecture1ans lecture1
ans lecture1pharmdude
 

Viewers also liked (20)

L5: Adrenergic agonists; sympathomimetics
L5: Adrenergic agonists; sympathomimeticsL5: Adrenergic agonists; sympathomimetics
L5: Adrenergic agonists; sympathomimetics
 
Autonomic nervous system lecture 5
Autonomic nervous system lecture 5 Autonomic nervous system lecture 5
Autonomic nervous system lecture 5
 
L1: Drugs acting on the ANS
L1: Drugs acting on the ANSL1: Drugs acting on the ANS
L1: Drugs acting on the ANS
 
Oxymetazoline 1491-59-4-api
Oxymetazoline 1491-59-4-apiOxymetazoline 1491-59-4-api
Oxymetazoline 1491-59-4-api
 
Affective disorders
Affective disordersAffective disorders
Affective disorders
 
Antidepressants /certified fixed orthodontic courses by Indian dental academy
Antidepressants  /certified fixed orthodontic courses by Indian dental academy Antidepressants  /certified fixed orthodontic courses by Indian dental academy
Antidepressants /certified fixed orthodontic courses by Indian dental academy
 
Pharmacology of adrenergic neuron blockers
Pharmacology of adrenergic neuron blockersPharmacology of adrenergic neuron blockers
Pharmacology of adrenergic neuron blockers
 
Adrenergic agents lady ann
Adrenergic agents   lady annAdrenergic agents   lady ann
Adrenergic agents lady ann
 
Anti depressent drugs
Anti depressent drugsAnti depressent drugs
Anti depressent drugs
 
Reversal action of Acetylcholine on blood pressure in dog
Reversal action of Acetylcholine on blood pressure in dogReversal action of Acetylcholine on blood pressure in dog
Reversal action of Acetylcholine on blood pressure in dog
 
adrenergic agonists & antagonists
adrenergic agonists & antagonistsadrenergic agonists & antagonists
adrenergic agonists & antagonists
 
Dr. baltazar s adrenergic agonists
Dr. baltazar s adrenergic agonistsDr. baltazar s adrenergic agonists
Dr. baltazar s adrenergic agonists
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part II
 
05 antidepressants by ravikiran
05 antidepressants by ravikiran 05 antidepressants by ravikiran
05 antidepressants by ravikiran
 
Antidepressants
AntidepressantsAntidepressants
Antidepressants
 
Anticholinergic pharmacology
Anticholinergic pharmacologyAnticholinergic pharmacology
Anticholinergic pharmacology
 
Histamin antihistamin
Histamin antihistaminHistamin antihistamin
Histamin antihistamin
 
ans lecture1
ans lecture1ans lecture1
ans lecture1
 
Obat antihistamin dan abat
Obat antihistamin dan abatObat antihistamin dan abat
Obat antihistamin dan abat
 
Asma 2
Asma 2Asma 2
Asma 2
 

Similar to L6: adrenergic neurotransmition/ agonists

VASOCONSTRICTORS
VASOCONSTRICTORSVASOCONSTRICTORS
VASOCONSTRICTORSreshm007
 
Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology Areej Abu Hanieh
 
Adrenergic System.pptx
Adrenergic System.pptxAdrenergic System.pptx
Adrenergic System.pptxZainAliKhan17
 
Lec 8 adrenergic system (1).pdf 2000245
Lec 8  adrenergic system (1).pdf 2000245Lec 8  adrenergic system (1).pdf 2000245
Lec 8 adrenergic system (1).pdf 2000245AliSajjadShemmran
 
Adrenergic agonist & antagonist
Adrenergic agonist & antagonist  Adrenergic agonist & antagonist
Adrenergic agonist & antagonist Ankhzaya Zaya
 
adrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxadrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxayman255825
 
Adrenergic system and drugs
Adrenergic system and drugsAdrenergic system and drugs
Adrenergic system and drugsBikashAdhikari26
 
7.Adrenergic agonists.ppt
7.Adrenergic agonists.ppt7.Adrenergic agonists.ppt
7.Adrenergic agonists.pptssuser7b172e
 
adrenergic agonists for all medical students
adrenergic agonists for all medical studentsadrenergic agonists for all medical students
adrenergic agonists for all medical studentsSamiUllahMukhlis
 
Inotropes and vasopressors
Inotropes and vasopressorsInotropes and vasopressors
Inotropes and vasopressorspankaj rana
 
ANS PHARMACOLOGY PHARMACY 02 midwife 2015.pptx
ANS PHARMACOLOGY PHARMACY 02 midwife 2015.pptxANS PHARMACOLOGY PHARMACY 02 midwife 2015.pptx
ANS PHARMACOLOGY PHARMACY 02 midwife 2015.pptxwakogeleta
 
Pharmacology of-vasopressors-and-inotropes
Pharmacology of-vasopressors-and-inotropesPharmacology of-vasopressors-and-inotropes
Pharmacology of-vasopressors-and-inotropesCorey Ahmad
 

Similar to L6: adrenergic neurotransmition/ agonists (20)

L5 ans pharmacology 17 18
L5 ans pharmacology 17 18L5 ans pharmacology 17 18
L5 ans pharmacology 17 18
 
VASOCONSTRICTORS
VASOCONSTRICTORSVASOCONSTRICTORS
VASOCONSTRICTORS
 
Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 
Sympathomimetic
SympathomimeticSympathomimetic
Sympathomimetic
 
sympathomimetic
sympathomimeticsympathomimetic
sympathomimetic
 
Adrenergic System.pptx
Adrenergic System.pptxAdrenergic System.pptx
Adrenergic System.pptx
 
Lec 8 adrenergic system (1).pdf 2000245
Lec 8  adrenergic system (1).pdf 2000245Lec 8  adrenergic system (1).pdf 2000245
Lec 8 adrenergic system (1).pdf 2000245
 
Adrenergic agonist & antagonist
Adrenergic agonist & antagonist  Adrenergic agonist & antagonist
Adrenergic agonist & antagonist
 
adrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxadrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptx
 
adrenergic-180630054152.pdf
adrenergic-180630054152.pdfadrenergic-180630054152.pdf
adrenergic-180630054152.pdf
 
Adrenergic system and drugs
Adrenergic system and drugsAdrenergic system and drugs
Adrenergic system and drugs
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 
7.Adrenergic agonists.ppt
7.Adrenergic agonists.ppt7.Adrenergic agonists.ppt
7.Adrenergic agonists.ppt
 
adrenergic agonists for all medical students
adrenergic agonists for all medical studentsadrenergic agonists for all medical students
adrenergic agonists for all medical students
 
Inotropes and vasopressors
Inotropes and vasopressorsInotropes and vasopressors
Inotropes and vasopressors
 
ANS PHARMACOLOGY PHARMACY 02 midwife 2015.pptx
ANS PHARMACOLOGY PHARMACY 02 midwife 2015.pptxANS PHARMACOLOGY PHARMACY 02 midwife 2015.pptx
ANS PHARMACOLOGY PHARMACY 02 midwife 2015.pptx
 
Pharmacology of-vasopressors-and-inotropes
Pharmacology of-vasopressors-and-inotropesPharmacology of-vasopressors-and-inotropes
Pharmacology of-vasopressors-and-inotropes
 
Sympathomimmetics
SympathomimmeticsSympathomimmetics
Sympathomimmetics
 
Inotropesfs
InotropesfsInotropesfs
Inotropesfs
 

More from College of Pharmacy University of Sulaimani

More from College of Pharmacy University of Sulaimani (19)

L7 ans pharmacology 17 18
L7 ans pharmacology 17 18L7 ans pharmacology 17 18
L7 ans pharmacology 17 18
 
L3 ans pharmacology 2017 2018
L3 ans pharmacology 2017 2018L3 ans pharmacology 2017 2018
L3 ans pharmacology 2017 2018
 
L4 ans pharmacology 17 18
L4 ans pharmacology 17 18L4 ans pharmacology 17 18
L4 ans pharmacology 17 18
 
L6 ans pharmacology 17 18
L6 ans pharmacology 17 18L6 ans pharmacology 17 18
L6 ans pharmacology 17 18
 
L2 ans pharmacology 2017 2018
L2 ans pharmacology 2017 2018L2 ans pharmacology 2017 2018
L2 ans pharmacology 2017 2018
 
Antihypertensive drugs 2015-16
Antihypertensive drugs 2015-16Antihypertensive drugs 2015-16
Antihypertensive drugs 2015-16
 
Heart failure
Heart failureHeart failure
Heart failure
 
Diuretics
DiureticsDiuretics
Diuretics
 
Antiarrythmic drugs
Antiarrythmic drugsAntiarrythmic drugs
Antiarrythmic drugs
 
Antianginal drugs
Antianginal drugsAntianginal drugs
Antianginal drugs
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
L7
L7L7
L7
 
L2
L2L2
L2
 
L 4: Cholinergic antagonists
L 4: Cholinergic antagonistsL 4: Cholinergic antagonists
L 4: Cholinergic antagonists
 
L3:cholinomimetics
L3:cholinomimeticsL3:cholinomimetics
L3:cholinomimetics
 
L8: B-adrenergic blockers
L8: B-adrenergic blockersL8: B-adrenergic blockers
L8: B-adrenergic blockers
 
local anesthetics
local anestheticslocal anesthetics
local anesthetics
 
Week 8 helping patients manage therapeutic regimens
Week 8 helping patients manage therapeutic regimensWeek 8 helping patients manage therapeutic regimens
Week 8 helping patients manage therapeutic regimens
 
Week 7 interviewing and assessement
Week 7 interviewing and assessementWeek 7 interviewing and assessement
Week 7 interviewing and assessement
 

Recently uploaded

VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...JRRolfNeuqelet
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...rightmanforbloodline
 
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessSigns It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessGokuldas Hospital
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...Halo Docter
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialSherrylee83
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsYash Garg
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxMohammadAbuzar19
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATROKanhu Charan
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesPHARMA IQ EDUCATION
 
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7grandmotherprocess99
 
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptx
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptxNegative Pressure Wound Therapy in Diabetic Foot Ulcer.pptx
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptxAdhithya Mullath Ullas
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifierNidhi Joshi
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024locantocallgirl01
 
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfBURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfDolisha Warbi
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answersShafnaP5
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTThomas Onyango Kirengo
 
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...rightmanforbloodline
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfMedicoseAcademics
 
Anti viral drug pharmacology classification
Anti viral drug pharmacology classificationAnti viral drug pharmacology classification
Anti viral drug pharmacology classificationNikitaPawar41153
 

Recently uploaded (20)

VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
 
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessSigns It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseases
 
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
 
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptx
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptxNegative Pressure Wound Therapy in Diabetic Foot Ulcer.pptx
Negative Pressure Wound Therapy in Diabetic Foot Ulcer.pptx
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfBURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
 
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
TEST BANK For Guyton and Hall Textbook of Medical Physiology, 14th Edition by...
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
 
Anti viral drug pharmacology classification
Anti viral drug pharmacology classificationAnti viral drug pharmacology classification
Anti viral drug pharmacology classification
 

L6: adrenergic neurotransmition/ agonists

  • 1. 128 June 2014 Adrenergic Agonists Pharmacology I/ Lecture 6 Dr. Hiwa K. Saaed, HD, MSc. PhD
  • 2. 28 June 2014 2 I. Direct-Acting • A. Epinephrine (α1, α2, β1, β2) 1.At low doses, β effects (vasodilation) on the vascular system predominate, 2.whereas at high doses, α effects (vasoconstriction) are strongest.
  • 3. 28 June 2014 3 Cardiovascular Actions: Cardiovascular: • β1 action: positive inotropic & chronotropic. • α effects : constricts arterioles in the skin, mucous membranes, and viscera. • β2 effects: dilates vessels going to the liver and skeletal muscle. • Renal blood flow is decreased. • Therefore, the cumulative effect is an increase in systolic blood pressure, coupled with a slight decrease in diastolic pressure
  • 5. 28 June 2014 5 Respiratory Actions Respiratory: • β2 action: powerful bronchodilation. Epinephrine also inhibits the release of allergy mediators such as histamines from mast cells. This action relieves all known allergic- or histamine- induced bronchoconstriction. In the case of anaphylactic shock, this can be lifesaving. In individuals suffering from an acute asthmatic attack, epinephrine 1. rapidly relieves the dyspnea (labored breathing) 2. increases the tidal volume (volume of gases inspired and expired).
  • 6. 28 June 2014 6 Metabolic Actions • Significant hyperglycemia: because of β2 effect: increased glycogenolysis in the liver, β2 effect: increased release of glucagon α2 effect: a decreased release of insulin.
  • 7. 28 June 2014 7 Actions • Lipolysis: through its agonist activity on the β receptors of adipose tissue, • which upon stimulation activate adenylyl cyclase to increase cAMP levels. • Cyclic AMP stimulates a hormone-sensitive lipase, • which hydrolyzes triacylglycerols to free fatty acids and glycerol.
  • 8. 28 June 2014 8 Therapeutic uses • Bronchospasm: in treatment of acute asthma and anaphylactic shock, epinephrine is the drug of choice; within a few minutes after SC administration, greatly improved respiratory exchange is observed. • Anaphylactic shock: Epinephrine is the drug of choice for the treatment of Type I hypersensitivity reactions in response to allergens.
  • 9. 28 June 2014 9 Therapeutic uses • Glaucoma: In ophthalmology, a 2% epinephrine solution may be used topically to reduce IOP in open-angle glaucoma. • It reduces the production of aqueous humor by vasoconstriction of the ciliary body blood vessels. • Cardiac arrest: Epinephrine may be used to restore cardiac rhythm in patients with cardiac arrest regardless of the cause.
  • 10. Therapeutic uses • Anesthetics: Local anesthetic solutions usually contain 1:100,000 parts epinephrine. The effect of the drug is to greatly increase the duration of the local anesthesia. • Very weak solutions of epinephrine (1:100,000) can also be used topically to vasoconstrict mucous membranes to control oozing of capillary blood. 28 June 2014 10
  • 11. 28 June 2014 11 Pharmacokinetics: • Epinephrine has a rapid onset but a brief duration of action • In emergency situations, epinephrine is given I.V. It may also be given SC, by endotracheal tube, by inhalation, or topically to the eye. • Oral administration is ineffective, because ? • Only metabolites are excreted in the urine.
  • 12. 28 June 2014 12 Adverse effects: • CNS disturbances: include anxiety, fear, tension, headache, and tremor. • Cerebral Hemorrhage: as a result of a marked elevation of blood pressure. • Cardiac arrhythmias: particularly if the patient is receiving digitalis. • Pulmonary edema.
  • 13. 28 June 2014 13 B. Norepinephrine (α1, α2, β1) • It should theoretically stimulate all types of adrenergic receptors. • In therapeutic doses, the α-adrenergic receptor is most affected.
  • 14. 28 June 2014 14 Cardiovascular actions: • Vasoconstriction: increase in peripheral resistance due to intense vasoconstriction of most vascular beds, including the kidney (α1 effect). • Both systolic and diastolic blood pressures increase. • Note: Norepinephrine causes greater vasoconstriction than does epinephrine, • because it does not induce compensatory vasodilation via β2 receptors on blood vessels supplying skeletal muscles, etc. • The weak β2 activity of norepinephrine also explains why it is not useful in the treatment of asthma.
  • 16. 28 June 2014 16 • Baroreceptor reflex: In isolated cardiac tissue, norepinephrine stimulates cardiac contractility; however, in vivo, no cardiac stimulation is noted. • This is due to the increased blood pressure that induces a reflex rise in vagal activity by stimulating the baroreceptors. • This reflex bradycardia is sufficient to counteract the local actions of norepinephrine on the heart,. Cardiovascular actions:
  • 17. 28 June 2014 17 Effect of atropine pretreatment: • If atropine, which blocks the transmission of vagal effects, is given before norepinephrine, then norepinephrine stimulation of the heart is evident as tachycardia.
  • 18. 28 June 2014 18 Therapeutic uses: • Shock However, metaraminol is favored, because it does not reduce blood flow to the kidney, as does norepinephrine.
  • 19. 28 June 2014 19 • Other actions of norepinephrine are not considered to be clinically significant. • It is never used for asthma or in combination with local anesthetics. • Norepinephrine is a potent vasoconstrictor and will cause extravasation (discharge of blood from vessel into tissues) along the injection site. Therapeutic uses:
  • 20. 28 June 2014 20 C. Isoproterenol (β1- and β2) • is a direct-acting synthetic catecholamine • predominantly stimulates both β1- and β2. • Its nonselectivity is one of its drawbacks and the reason why it is rarely used therapeutically. • Its action on α receptors is insignificant.
  • 21. 28 June 2014 21 Actions: • Cardiovascular: • β1 effect: increase heart rate and force of contraction, causing increased CO. It is useful in the treatment of atrioventricular block or cardiac arrest. • β2 effect: dilates the arterioles of skeletal muscle , resulting in decreased peripheral resistance. • Because of its cardiac stimulatory action, it may increase systolic blood pressure slightly, but it greatly reduces mean arterial and diastolic blood pressure. • Other effects on β receptors, such as increased blood sugar and lipolysis.
  • 23. 28 June 2014 23 Therapeutic uses: Isoproterenol • is now rarely used as a bronchodilator in asthma. • It can be employed to stimulate the heart in emergency situations
  • 25. 28 June 2014 25 D. Dopamine (D1 and D2, β1, α1) • Dopamine can activate α- and β-adrenergic receptors, • at higher doses, it can cause vasoconstriction by activating α1 receptors, • whereas at lower doses, it stimulates β1 cardiac receptors. • In addition, D1 and D2 dopaminergic receptors, occur in the peripheral mesenteric and renal vascular beds, where binding of dopamine produces vasodilation.
  • 26. 28 June 2014 26 Actions: • Cardiovascular: β1, α1 receptors • Renal and visceral: Dopamine dilates renal and splanchnic arterioles by activating dopaminergic receptors, thus increasing blood flow to the kidneys and other viscera. • Therefore, dopamine is clinically useful in the treatment of shock, in which significant increases in sympathetic activity might compromise renal function.
  • 27. 28 June 2014 27 Therapeutic uses: • Shock: Dopamine is the drug of choice for shock and is given by continuous infusion. It raises the blood pressure by stimulating the: • β1 receptors on the heart to increase cardiac output, • α1 receptors on blood vessels to increase total peripheral resistance. • In addition, it enhances perfusion to the kidney and splanchnic areas, An increased blood flow to the kidney enhances the glomerular filtration rate and causes sodium diuresis. • In this regard, dopamine is far superior to norepinephrine, which diminishes the blood supply to the kidney and may cause renal shutdown.
  • 28. 28 June 2014 28 E. Dobutamine (β1) • is a synthetic, direct-acting catecholamine that is a β1-receptor agonist. • It increases cardiac rate and output with few vascular effects.
  • 29. 28 June 2014 29 Therapeutic uses: • CHF: to increase CO in congestive heart failure as well as for inotropic support after cardiac surgery. • The drug increases cardiac output with little change in heart rate, and it does not significantly elevate oxygen demands of the myocardium a major advantage over other sympathomimetic drugs.
  • 30. 28 June 2014 30 F. Oxymetazoline (α1 and α2) • Oxymetazoline is a direct-acting synthetic adrenergic agonist that stimulates both α1- and α2-adrenergic receptors. • It is primarily used locally in the eye or the nose as a vasoconstrictor. • Oxymetazoline is found in many over-the- counter short-term nasal spray decongestant products as well as in ophthalmic drops for the relief of redness of the eyes associated with swimming, colds, or contact lens.
  • 31. 28 June 2014 31 The mechanism of action • The mechanism of action of oxymetazoline is direct stimulation of α receptors on blood vessels supplying the nasal mucosa and the conjunctiva to reduce blood flow and decrease congestion. • Oxymetazoline is absorbed in the systemic circulation regardless of the route of administration and may produce nervousness, headaches, and trouble sleeping. When administered in the nose, burning of the nasal mucosa and sneezing may occur. • Rebound congestion is observed with long-term use.
  • 32. 28 June 2014 32 G. Phenylephrine (α1) • Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors and favors α1 receptors over α2 receptors. • Phenylephrine is a vasoconstrictor that raises both systolic and diastolic blood pressures. • It has no effect on the heart itself but rather induces reflex bradycardia when given parenterally.
  • 33. 28 June 2014 33 Phenylphrine • It is often used topically on the nasal mucous membranes as decongestant and in ophthalmic solutions for mydriasis. • The drug is used to raise blood pressure and to terminate episodes of supraventricular tachycardia. • Large doses can cause hypertensive headache and cardiac irregularities.
  • 34. 28 June 2014 34 H. Methoxamine (α1) • Methoxamine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors, with α1 receptors favored over α2 receptors. • Methoxamine raises blood pressure by stimulating α1 receptors in the arterioles, causing vasoconstriction. This causes an increase in total peripheral resistance.
  • 35. 28 June 2014 35 Methoxamine • Clinically used to relieve attacks of paroxysmal supraventricular tachycardia. • It is also used to overcome hypotension during surgery involving halothane anesthetics. • In contrast to most other adrenergic drugs, methoxamine does not tend to trigger cardiac arrhythmias in the heart, which is sensitized by these general anesthetics. • Adverse effects include hypertensive headache and vomiting.
  • 36. 28 June 2014 36 I. Clonidine (α2) • Clonidine is an α2 agonist; acts centrally to produce inhibition of sympathetic vasomotor centers, decreasing sympathetic outflow to the periphery. • used in essential hypertension to lower blood pressure. • It can be used to minimize the symptoms that accompany withdrawal from opiates or benzodiazepines.
  • 37. 28 June 2014 37 J. Metaproterenol (β2) • It can be administered orally or by inhalation. • The drug acts primarily at β2 receptors, producing little effect on the heart. • The drug is useful as a bronchodilator in the treatment of asthma and to reverse bronchospasm.
  • 38. 28 June 2014 38 K. Albuterol, pirbuterol, and terbutaline (β2) • are short-acting β2 agonists used primarily as bronchodilators and administered by a metered-dose inhaler. • Compared with the nonselective β- adrenergic agonists, such as metaproterenol, these drugs produce equivalent bronchodilation with less cardiac stimulation.
  • 39. 28 June 2014 39 L. Salmeterol and formoterol (β2) • are β2-adrenergic selective, long-acting bronchodilators. over 12 hours, compared with less than 3 hours for albuterol. • Unlike formoterol, however, salmeterol has a somewhat delayed onset of action. • These agents are not recommended as monotherapy and are highly efficacious when combined with a corticorsteroid. • Salmeterol and formoterol are the agents of choice for treating nocturnal asthma in symptomatic patients taking other asthma medications.
  • 41. 28 June 2014 41 II. Indirect-Acting Adrenergic Agonists • cause norepinephrine release from presynaptic terminals or inhibit the uptake of norepinephrine. • Thus, they potentiate the effects of norepinephrine produced endogenously, • but these agents do not directly affect postsynaptic receptors.
  • 42. 28 June 2014 42 A. Amphetamine • The marked central stimulatory action of amphetamine is often mistaken by drug abusers as its only action. • However, the drug can increase blood pressure significantly by α-agonist action on the vasculature as well as β-stimulatory effects on the heart.
  • 43. 28 June 2014 43 Uses The CNS stimulant effects of amphetamine and its derivatives have led to their use for treating: 1. hyperactivity in children, 2. narcolepsy, 3. and appetite control. Its use in pregnancy should be avoided
  • 44. 28 June 2014 44 B. Tyramine • Tyramine is not a clinically useful drug, but it is important because it is found in fermented foods, such as ripe cheese and Chianti wine. It is a normal byproduct of tyrosine metabolism. • Normally, it is oxidized by MAO in the gastrointestinal tract, but if the patient is taking MAO inhibitors, it can precipitate serious vasopressor episodes. • Like amphetamines, tyramine can enter the nerve terminal and displace stored norepinephrine. The released catecholamine then acts on adrenoceptors.
  • 45. 28 June 2014 45 C. Cocaine • Cocaine is unique among local anesthetics in having the ability to block the Na+/K+-activated ATPase (required for cellular uptake of norepinephrine) on the cell membrane of the adrenergic neuron. • Consequently, norepinephrine accumulates in the synaptic space, • Like amphetamines, it can increase blood pressure by α- agonist actions and β-stimulatory effects. • Cocaine as a CNS stimulant and drug of abuse.
  • 46. 28 June 2014 46 VI. Mixed-Action Adrenergic Agonists 1. induce the release of norepinephrine from presynaptic terminals, 2. and they activate adrenergic receptors on the postsynaptic membrane.
  • 47. 28 June 2014 47 A. Ephedrine and pseudoephedrine • Are plant alkaloids that are now made synthetically. • are not catechols and are poor substrates for COMT and MAO; thus, these drugs have a long duration of action. • have excellent absorption orally and penetrate into the CNS; however, pseudoephedrine has fewer CNS effects.
  • 48. 28 June 2014 48 A. Ephedrine and pseudoephedrine • Ephedrine raises systolic and diastolic blood pressures by vasoconstriction and cardiac stimulation. • Ephedrine produces bronchodilation, but it is less potent than epinephrine or isoproterenol in this regard and produces its action more slowly. • It is therefore sometimes used prophylactically in chronic treatment of asthma to prevent attacks rather than to treat the acute attack.
  • 49. 28 June 2014 49 A. Ephedrine and pseudoephedrine • Ephedrine enhances contractility and improves motor function in myasthenia gravis, particularly when used in conjunction with anticholinesterases. • Ephedrine produces a mild stimulation of the CNS. This increases alertness, decreases fatigue, and prevents sleep. It also improves athletic performance.
  • 50. 28 June 2014 50 A. Ephedrine and pseudoephedrine • Ephedrine has been used to treat asthma, as a nasal decongestant (due to its local vasoconstrictor action), and to raise blood pressure. • Note: The clinical use of ephedrine is declining due to the availability of better, more potent agents that cause fewer adverse effects. • Pseudoephedrine is primarily used to treat nasal and sinus congestion or congestion of the eustachian tubes.
  • 51. 28 June 2014 51 A. Ephedrine and pseudoephedrine • Ephedrine-containing herbal supplements (mainly ephedra-containing products) were banned by the Food and Drug Administration (FDA) in April 2004 because of life-threatening cardiovascular reactions. • Pseudoephedrine has been illegally converted to methamphetamine. Thus, products containing pseudoephedrine have certain restrictions and must be kept behind the sales counter.]
  • 52. 28 June 2014 52 B. Metaraminol: • mixed acting sympathomimetic similar to NE in its action although it is less potent. • Increase systolic and diastolic BP via vasoconstriction and rapid marked reflex bradycardia. • Rx of hypotension and termination of PAT episodes.